SaurabhSMahabirM. Adverse ocular events on miltefosine treatment for post-kala-azar dermal leishmaniasis in India. Trop Doct2020; 50: 37–42.
2.
World Health Organization. Control of the Leishmaniases. WHO Technical Report Series 949, Geneva: WHO, 2010. Available at: http://whqlibdoc.who.int/trs/WHO_TRS_949_eng.pdf (accessed on 25 October 2019).
3.
MusaMKhalilEAGYounisBM, et al.Treatment-Based Strategy for the Management of Post-Kala-Azar Dermal Leishmaniasis Patients in the Sudan. J Trop Med2013; 2013: 708391–708391.
